Frost & Sullivan
Frost & Sullivan

Gene Therapy Process Development 2.0 – What’s Next?

Gene therapy continues to experience explosive growth driven by the development of better assays, more-frequent outsourcing to contract development and manufacturing organizations (CDMOs), greater capital investment, and the rise of plug-and-play platform technologies. Still, challenges loom: viral vectors can cause unwanted immune responses, standardized analytics and assays lag, regulatory guidance is still forming, and manufacturing remains difficult and expensive, resulting in unaffordable prices. How will challenges and potential breakthroughs affect the future of gene therapy process development?

Download this complimentary Article to discover:

  • The Regulatory Environment of Gene Therapy Process Development
  • Opportunities for Cell and Gene Therapy
  • New Trends and the Future of Gene Therapy
  • Industry Leaders’ Perspective on Gene Therapy

Download the Complimentary Article

"*" indicates required fields

Name*

This article is co-hosted in partnership with Frost & Sullivan and 3M. As a result, both 3M and Frost & Sullivan are collecting your personal data when you submit such information as part of the registration process above. For more information on each party’s privacy practices, please see: 3M Privacy Notice** | Frost & Sullivan Privacy Notice.

Fros & Sullivan privacy*

Would you like to receive email updates from 3M?*
Would you like to speak with a 3M Technical Expert?*

**The information you provide are used by 3M Company and its group companies, in accordance with 3M Global Privacy Policy, for the purpose of (i) following up with you via email or telephone on this event sponsored / co-organized / participated by 3M, your questions, interests or requests; (ii) making materials available to you; and (iii) inviting you to future events; and (iv) based on your consent, sending you newsletters, advertisements, surveys and information about promotions and offers of 3M Company and its group companies via email. Please use the Intake form to object. EMEA residents: please read 3M privacy notice, opt in language & exact information on 3M data controller relevant to your location Here.

This field is for validation purposes and should be left unchanged.